Aspargo Labs, Inc. ("Aspargo Labs" or the "Company"), a specialty pharmaceutical and MedTech company focused on converting ...

Dr. Mehmet Oz, the heart surgeon turned daytime TV star, was confirmed Thursday to lead the Centers for Medicare and Medicaid ...

Drawing from real experience in industry, education, and regulation, I advocate for pharmaceutical reindustrialization as a driver of sovereignty and progress. Certified science, technical training, ...

This brief covers significant developments in health, including FTC's hold on an insulin lawsuit, Hungary's outbreak control ...

Ex-vaccine regulator Peter Marks promoted "ineffective therapy that gave patients false hope, eroded trust in the regulatory process and provided nothing but risk and cost to Americans," Stanford ...

Amid a raft of federal changes cutting funding and capacities at the Food and Drug Administration, investors are soon ...

Amid growing legislative pressures and industry debates, pharmacy benefit managers (PBMs) are exploring new strategies to ...

This article examines post-market drug safety, highlighting surveillance mechanisms, regulatory responses, and case studies of approved drugs with hidden risks.

UK is monitoring the global reaction to the announced tariffs and the implications for our sector in the UK and abroad.

India could potentially lose $6 billion or 0.16 per cent GDP in exports to the US at 10 per cent broad tariffs, with this ...

Oxana Kolosova of iVrach.com explores the Russian pharma market in pharmaphorum's ... As a result, a regulatory regime that favors local manufacturers was introduced. This left foreign companies ...

Deep-pocketed investors have adopted a bullish approach towards Teva Pharmaceutical Indus (NYSE:TEVA), and it's something market players shouldn't ignore. Our tracking of public options records at ...